mymobility Care Management Platform
Search documents
How the OneStep Partnership Could Drive Growth for ZBH Stock
ZACKS· 2025-12-17 14:01
Core Insights - Zimmer Biomet Holdings, Inc. (ZBH) has entered into an exclusive collaboration with OneStep, a digital fall prevention and mobility intelligence platform, to enhance recovery tracking for joint replacement surgery patients [1][4][7] Company Developments - The collaboration will integrate OneStep's gait and mobility analytics into Zimmer Biomet's mymobility Care Management Platform, providing daily insights for patients from surgical preparation through recovery [4][5][6] - Zimmer Biomet's mymobility platform offers a guided orthopedic patient experience, including education, surveys, and video-guided post-operative exercises, supported by automation and data insights [5] - The integration of OneStep's technology supports Zimmer Biomet's connected care strategy, enhancing the ability to monitor recovery trends and tailor rehabilitation programs [6][7] Financial Performance - Zimmer Biomet has a market capitalization of $18.02 billion and an earnings yield of 8.3%, significantly higher than the industry average of 0.2% [3] - The company has delivered an average earnings surprise of 2.2% over the trailing four quarters [3] Industry Outlook - The global joint replacement market was valued at $17.1 billion in 2020 and is projected to reach $25.4 billion by 2028, growing at a compound annual growth rate (CAGR) of 3.4% from 2021 to 2028, driven by the increasing prevalence of orthopedic disorders [8] Recent Developments - Zimmer Biomet received FDA 510(k) clearance for its ROSA Knee with OptimiZe, an enhanced version of its robotic-assisted total knee replacement system, aimed at providing a more customized surgical experience [9] Stock Performance - Following the announcement of the collaboration, Zimmer Biomet's shares fell by 1.6%, but the collaboration is expected to support a rebound in stock performance [2] - Over the past year, ZBH shares have decreased by 15.9%, contrasting with the industry's growth of 0.5% [10]
Zimmer Biomet, OneStep Collaborate to Provide Enhanced Mobility Data to Patients and Surgeons to Help Improve Joint Procedure Recovery
Prnewswire· 2025-12-16 12:30
Core Insights - Zimmer Biomet and OneStep have entered into an exclusive collaboration to enhance recovery monitoring in orthopedic surgery through comprehensive mobility data integration [1][2][4]. Company Overview - Zimmer Biomet is a global leader in medical technology, focusing on maximizing mobility and improving health through innovative products and integrated digital solutions [6][7]. - OneStep is an FDA-listed digital care platform that captures gait, balance, and mobility data using smartphones, aimed at improving patient care and monitoring [9]. Collaboration Details - The partnership will integrate OneStep's gait and mobility analytics into Zimmer Biomet's mymobility Care Management Platform, allowing for remote assessment of patients' recovery progress [3][4]. - The mymobility platform provides a comprehensive patient experience, including education, surveys, check-ins, and telehealth applications, all aimed at enhancing recovery monitoring [4]. Technological Integration - OneStep's mobility intelligence is based on the analysis of over one million gait cycles daily, providing a substantial real-world mobility dataset to support clinicians in tailoring rehabilitation programs [4]. - The integration aims to transform gait and mobility into vital signs, empowering both patients and providers with clinically meaningful data [4].
Zimmer Biomet Highlights Robotics & Musculoskeletal Product Innovations at 2025 AAHKS Annual Meeting
Prnewswire· 2025-10-21 11:30
Core Insights - Zimmer Biomet Holdings, Inc. is showcasing its innovations in robotics and musculoskeletal solutions at the 2025 annual meeting of the American Association of Hip and Knee Surgeons (AAHKS) [1][2] - The company emphasizes the urgency for advanced orthopedic solutions due to an aging population and rising patient expectations for less disruption and faster recovery [3] Product Highlights - The mBôsâ™ TKA System is a CT-based, semi-autonomous robotic technology for total knee arthroplasty that has received FDA 510(k) clearance, with a fully autonomous version in clinical trials [7] - The ROSA Knee with OptimiZe™ is the latest version of the ROSA Knee System, pending FDA clearance, designed to enhance surgical planning and accuracy [7] - The TMINI Miniature Robotic System is a handheld, wireless CT-based robotic system for precise implant placement [7] - ZBEdge Analytics provides intra-operative insights via a smartphone application, allowing surgeons to assess performance and clinical decisions [7] - The mymobility Care Management Platform offers continuous data and patient feedback to improve surgical preparation and recovery [7] - The Oxford Cementless Partial Knee is the only FDA-approved mobile cementless partial knee implant in the U.S., known for its efficiency and survivorship [7] - The Persona OsseoTi Keel Tibia is a cementless tibia for TKA featuring a 3D printed porous tray for stable fixation [7] - The Persona® SoluTion™ PPS® Femur is designed for patients with metal sensitivities, featuring a porous coating for cementless fixation [7] - Persona IQ The Smart Knee captures patient-specific metrics for post-operative insights, enhancing the TKA patient experience [7] Strategic Vision - The company aims to lead in orthopedic innovation by integrating robotics, digital platforms, and AI to improve surgical precision and patient outcomes [3][9] - Zimmer Biomet's commitment to innovation is highlighted as the most ambitious cycle in its history, positioning it to deliver comprehensive orthopedic solutions [3]